Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 (ELEVATE-TIMI56)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2011 by The TIMI Study Group.
Recruitment status was  Active, not recruiting
Bristol-Myers Squibb
Information provided by:
The TIMI Study Group Identifier:
First received: November 2, 2010
Last updated: October 4, 2011
Last verified: October 2011